Leading biopharmaceutical company aims to build on record-setting 2021 thanks to its industry-leading products and innovation pipeline across its six therapeutic areas: vaccines, oncology, inflammation and immunology, internal medicine, rare diseases, and anti-infectives and sterile injectables • Pfizer delivered medicines to more than 4.1 million patients across Africa and the Middle East in 2021, and is aiming to increase this by 45% in 2022 • Regional plan is to continue leading COVID-19 prevention and care, while also planning to have more than 50 product launches this year across AfME • The company is committed to driving health equity across the region, hoping to support the lives of over 10,000 patients in 2022 through its access programs